{"total_count":10036987,"current_page":367346,"per_page":20,"docs":[{"id":9951752,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFPRINCIPALS_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Long Term Debt Maturities Repayments Of Principals","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Long-Term-Debt-Maturities-Repayments-Of-Principals","description":"SEC Name: LongTermDebtMaturitiesRepaymentsOfPrincipals","updated_at":"2014-02-19T01:44:03Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951751,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFPRINCIPALS_Q","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Long Term Debt Maturities Repayments Of Principals","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Long-Term-Debt-Maturities-Repayments-Of-Principals","description":"SEC Name: LongTermDebtMaturitiesRepaymentsOfPrincipals","updated_at":"2014-02-19T01:44:16Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951753,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_OPERATINGLEASESFUTUREMINIMUMPAYMENTS_Q","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Operating Leases Future Minimum Payments","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Operating-Leases-Future-Minimum-Payments","description":"SEC Name: OperatingLeasesFutureMinimumPayments","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951754,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_OPERATINGLEASESFUTUREMINIMUMPAYMENTS_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Operating Leases Future Minimum Payments","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Operating-Leases-Future-Minimum-Payments","description":"SEC Name: OperatingLeasesFutureMinimumPayments","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951755,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDANDEXERCISABLEWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM_Q","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-And-Exercisable-Weighted-Average-Remaining-Contractual-Term","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm","updated_at":"2014-02-19T01:44:03Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951756,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDANDEXERCISABLEWEIGHTEDAVERAGEREMAININGCONTRACTUALTERM_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-And-Exercisable-Weighted-Average-Remaining-Contractual-Term","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951578,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_EXPECTEDFUTUREINVESTMENT_Q","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Expected Future Investment","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Expected-Future-Investment","description":"SEC Name: ExpectedFutureInvestment","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2013-03-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951757,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_EXPECTEDFUTUREINVESTMENT_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Expected Future Investment","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Expected-Future-Investment","description":"SEC Name: ExpectedFutureInvestment","updated_at":"2014-02-19T01:44:04Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951758,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFINTEREST_Q","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Quarterly Long Term Debt Maturities Repayments Of Interest","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Quarterly-Long-Term-Debt-Maturities-Repayments-Of-Interest","description":"SEC Name: LongTermDebtMaturitiesRepaymentsOfInterest","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951759,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_LONGTERMDEBTMATURITIESREPAYMENTSOFINTEREST_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Long Term Debt Maturities Repayments Of Interest","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Long-Term-Debt-Maturities-Repayments-Of-Interest","description":"SEC Name: LongTermDebtMaturitiesRepaymentsOfInterest","updated_at":"2014-02-19T01:44:17Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951767,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSEXERCISESINPERIODTOTALINTRINSICVALUE_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Exercises-In-Period-Total-Intrinsic-Value","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue","updated_at":"2014-02-19T01:44:05Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951766,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_OTHERNONCASHINCOMEEXPENSE_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Other Noncash Income Expense","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Other-Noncash-Income-Expense","description":"SEC Name: OtherNoncashIncomeExpense","updated_at":"2014-02-19T01:44:05Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951772,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSEXPECTEDDIVIDENDRATE_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Expected-Dividend-Rate","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate","updated_at":"2014-02-19T01:44:05Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951774,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSRISKFREEINTERESTRATEMINIMUM_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Risk-Free-Interest-Rate-Minimum","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum","updated_at":"2014-02-19T01:44:19Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951797,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDFAIRVALUEASSUMPTIONSRISKFREEINTERESTRATEMAXIMUM_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Fair-Value-Assumptions-Risk-Free-Interest-Rate-Maximum","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum","updated_at":"2014-02-19T01:44:22Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951803,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSGRANTSINPERIODWEIGHTEDAVERAGEGRANTDATEFAIRVALUE_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Grants-In-Period-Weighted-Average-Grant-Date-Fair-Value","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue","updated_at":"2014-02-19T01:44:22Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951804,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_SHAREBASEDCOMPENSATIONARRANGEMENTBYSHAREBASEDPAYMENTAWARDOPTIONSVESTEDFAIRVALUE_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Share-Based-Compensation-Arrangement-By-Share-Based-Payment-Award-Options-Vested-Fair-Value","description":"SEC Name: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue","updated_at":"2014-02-19T01:44:23Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951808,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_CONTRIBUTIONSBYEMPLOYERTOPOSTEMPLOYMENTBENEFITOBLIGATIONS_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Contributions By Employer To Postemployment Benefit Obligations","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Contributions-By-Employer-To-Postemployment-Benefit-Obligations","description":"SEC Name: ContributionsByEmployerToPostemploymentBenefitObligations","updated_at":"2014-02-19T01:44:23Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951812,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_NETPROCEEDSFROMISSUANCEOFCOMMONSTOCK_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Net Proceeds From Issuance Of Common Stock","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Net-Proceeds-From-Issuance-Of-Common-Stock","description":"SEC Name: NetProceedsFromIssuanceOfCommonStock","updated_at":"2014-02-19T01:44:23Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null},{"id":9951813,"source_code":"SEC","source_name":"U.S. Securities and Exchange Commission","code":"ACRX_PROCEEDSFROMISSUANCEOFCLASSCOMMONSTOCKNETOFISSUANCECOSTS_A","name":"ACELRX PHARMACEUTICALS INC  (ACRX): Annual Proceeds From Issuance Of Class Common Stock Net Of Issuance Costs","urlize_name":"ACELRX-PHARMACEUTICALS-INC-ACRX-Annual-Proceeds-From-Issuance-Of-Class-Common-Stock-Net-Of-Issuance-Costs","description":"SEC Name: ProceedsFromIssuanceOfClassCommonStockNetOfIssuanceCosts","updated_at":"2014-02-19T01:44:23Z","frequency":"daily","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Value"],"private":false,"type":null,"display_url":null}],"sources":[{"id":651,"code":"SEC","datasets_count":4867,"description":"The Securities and Exchange commission is an agency of the United States government.\r\n\r\n\r\nTheir purpose is to regulate stock markets, and in doing so collect and distribute data on all publicly listed companies. ","name":"U.S. Securities and Exchange Commission","host":"www.sec.gov"}]}